Acasti PharmaACST 
$2.39-2.45%24h
-2.45%24h
Global rank29434
Market cap$17.77M
Change 7d-2.45%
YTD Performance-16.14%
SP500 benchmarkUnderperform
P/E-0.42
P/S0
Revenue$0
Earnings-$42.43M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Acasti Pharma (ACST)
Acasti Pharma has an EPS of $-5.7. In 2022, the company made an earnings per share (EPS) of $-1.62. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for ACST
-
Value:-
EPS history for Acasti Pharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$5.70 | 251.85% |
| 2022 | -$1.62 | -79.70% |
| 2021 | -$7.98 | -44.58% |
| 2020 | -$14.40 | - |
View the highest EPS stocks
